Industry: Healthcare
Published Date: November-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 172
Report ID: PMRREP34948
The North America orthokeratology market is projected to witness a CAGR of 5.8% during the forecast period from 2024 to 2031. It is anticipated to increase from US$ 172.6 Mn recorded in 2024 to a staggering US$ 256.2 Mn by 2031. Presence of key players like Paragon Vision Sciences, Euclid Systems Corporation, GP Specialists, and Art Optical Contact Lens, Inc. is projected to push demand.
The industry is experiencing robust growth due to increasing awareness of myopia management, particularly among children and adolescents. Rising prevalence of myopia, driven by prolonged screen time and reduced outdoor activities, has raised demand for effective non-surgical interventions.
The American Academy of Pediatrics (AAP), for instance, found that more than 80% of children exceed recommended screen time limits, which are set to 2 hours per day for non-educational purposes. Most kids and teenagers also do not meet the recommended amount of outdoor activity, which is 2 or more hours per day to lower their risk of myopia.
In children belonging to the age group of 6 to 12 years, the average outdoor time is 1 to 2 hours per day on weekends. Adolescents spend less than 1-hour daily outdoors. Favorable reimbursement policies and innovative healthcare infrastructure further bolster adoption.
Technological developments in orthokeratology lenses such as improved comfort and precision have enhanced patient satisfaction. Supportive initiatives by optometric associations to promote orthokeratology as a safe alternative to corrective surgeries and glasses contribute to market expansion. Besides, growing consumer preference for minimally invasive vision correction solutions is set to push demand.
Key Highlights of the Market
Market Attributes |
Key Insights |
North America Orthokeratology Market Size (2024E) |
US$ 172.6 Mn |
Projected Market Value (2031F) |
US$ 256.2 Mn |
North America Market Growth Rate (CAGR 2024 to 2031) |
5.8% |
Historical Market Growth Rate (CAGR 2019 to 2023) |
4.5% |
Category |
CAGR through 2031 |
Product Type- Overnight Ortho-K Lenses |
6.5% |
Overnight ortho-k lenses are leading in terms of market share due to their unmatched convenience and effectiveness. Designed to be worn during sleep, these lenses gently reshape the cornea. Hence, these enable users to experience clear vision throughout the day without the need for glasses or contact lenses.
The unique feature is particularly appealing to individuals with active lifestyles and those seeking non-surgical vision correction. Moreover, their proven efficacy in controlling myopia progression in children has significantly increased their adoption among parents and eye care professionals. For instance,
Innovations in lens technology, including materials with high oxygen permeability, ensure comfort and corneal health, further solidifying their market dominance.
Category |
CAGR through 2031 |
Material - Fluorosilicone Acrylate |
6.3% |
Fluorosilicone acrylate leads the North America orthokeratology industry due to its superior oxygen permeability. The feature is essential for maintaining corneal health during extended wear, especially overnight. The material offers enhanced durability, making the lenses resistant to scratches and deposits, thereby increasing their lifespan and cost-effectiveness. For instance,
Fluorosilicone acrylate provides excellent wettability and comfort, ensuring a better user experience compared to other materials. Its ability to balance rigidity with flexibility supports precise corneal reshaping, a key factor for orthokeratology success. These attributes, combined with growing consumer awareness of its benefits, make fluorosilicone acrylate the preferred choice for orthokeratology lens providers.
The North America orthokeratology market is experiencing significant growth, driven by increasing awareness of non-surgical vision correction methods, particularly for myopia management. Orthokeratology involves the use of specially designed contact lenses to reshape the cornea overnight. It is gaining high popularity among both children and adults as a safe alternative to glasses and daytime contact lenses.
Market trends show a rising demand for overnight ortho-k lenses due to their convenience and effectiveness in providing clear, unaided vision throughout the day. Fluorosilicone acrylate lenses, known for their superior oxygen permeability and comfort, are leading in material preference, ensuring better corneal health during wear.
Developments in lens technology and rising clinical evidence supporting the role of ortho-k in slowing myopia progression are fueling North America orthokeratology market growth. As the market continues to rise, factors like the increasing prevalence of myopia, technological innovations, and shift toward non-invasive treatments are set to shape its future trajectory.
The North America orthokeratology industry recorded a decent CAGR of 4.5% in the historical period from 2019 to 2023. It was fueled by rising awareness of myopia management and increasing adoption of non-surgical vision correction methods.
Over the years, orthokeratology has evolved from a niche treatment to a mainstream solution, particularly for children and young adults. They are seeking a way to correct vision without the use of glasses or daytime contact lenses. Technological developments in lens materials, such as the development of fluorosilicone acrylate lenses offering superior oxygen permeability and comfort, have further enhanced its appeal.
The market is anticipated to continue its upward trajectory through 2031. It will likely be driven by the increasing prevalence of myopia and increasing demand for convenient vision solutions. Also, robust clinical evidence supporting the effectiveness of orthokeratology in slowing myopia progression is anticipated to spur demand. As these trends evolve, innovations in lens design as well as rising consumer and healthcare provider awareness, are likely to define the future of North America.
Surging Telemedicine Integration to Augment Demand
The integration of telemedicine with orthokeratology services is a key driver in the North America orthokeratology market. By enabling remote consultations and monitoring, telemedicine improves patient accessibility and enhances operational efficiency for practitioners.
The integration allows providers to reach a larger patient base, optimally utilizing their time and resources. It also offers continuous follow-up care, boosting patient engagement and loyalty. As a result, orthokeratology providers are positioned as leaders in virtual care delivery, meeting the growing demand for easy-to-use healthcare solutions. This trend helps practices remain competitive, scalable, and adaptable in a rapidly evolving healthcare landscape.
Increasing Prevalence of Myopia to Spur Demand for Ortho-K
The global rise in myopia cases, particularly among younger populations, presents a significant growth opportunity for the North America orthokeratology industry. Orthokeratology is gaining popularity as a preferred solution for managing myopia progression due to its proven effectiveness in slowing the condition’s advancement.
Eye care professionals are increasingly incorporating ortho-k into their myopia management strategies, driving demand for orthokeratology products and services. This trend underscores the key role of proactive treatments in addressing the growing public health concern of myopia.
Infrastructure and Technology Gaps in Certain Areas to Limit Demand
One of the key factors hindering the North America orthokeratology market growth is the infrastructure and technology gaps in certain segments, particularly in the production of biologics and unique therapeutics. While the region’s pharmaceutical manufacturing infrastructure is well-established, a few areas still lag in terms of state-of-the-art facilities. These are mainly required for producing complex biologics, cell and gene therapies, and other high-tech products.
Domestic Contract Development and Manufacturing Organizations (CDMOs) must invest significantly in upgrading their manufacturing capabilities. They need to keep up with global demands for biosimilars, monoclonal antibodies, and innovative biologic drugs.
The lack of specialized facilities, equipment, and expertise in a few parts of Appalachia, Louisiana, and Mississippi can hinder North America’s ability to compete with highly advanced markets. As demand for such high-complexity products increases, this gap may limit the region’s growth potential in the biologics and advanced therapeutics sectors. Hence, significant investments need to be made to address these technological challenges.
Rising Age Demographics Creates New Opportunities for Key Participants
The evolution of ortho-k from being primarily a pediatric solution to a viable option for adults showcases its adaptability and sales potential across various age groups. Demand is rising among adults seeking vision correction options that align with their lifestyles.
Ortho-k manufacturers and practitioners are hence strategically adjusting their offerings to meet this booming market. This shift in demographics emphasizes the importance of targeted marketing strategies and product diversification to capitalize on emerging opportunities and ensure sustained growth.
Growing adoption of ortho-k among adults presents a significant chance to tap into a previously underexplored demographic. With increasing demand for convenient, non-invasive vision correction methods, ortho-k aligns well with consumer preferences for solutions that fit their active lifestyles.
Focused marketing strategies targeting both children and adults are set to boost brand awareness and product uptake. Additionally, the need for customized solutions drives innovation in lens designs and materials, enhancing patient satisfaction. Rising awareness of myopia management among both parents and adults further surges the market for proactive vision correction solutions.
The competitive landscape of the North America ortho k lenses industry is characterized by the dominance of key players like CooperVision, Bausch + Lomb, and Euclid Systems Corporation. These companies leverage their robust distribution networks, extensive research capabilities, and established reputations to maintain a strong foothold.
They focus on continuous innovation, offering orthokeratology lenses designed for enhanced myopia control, comfort, and safety. Strategic collaborations with optometrists and healthcare providers, coupled with targeted marketing campaigns, have been pivotal in strengthening their market presence. Additionally, their investments in clinical trials and regulatory compliance ensure product reliability and sustained customer trust.
Small-scale and emerging players, on the other hand, are augmenting competition through niche innovations and cost-effective solutions. These companies target underserved segments and specific age groups, such as pediatric patients with progressive myopia.
Partnerships with regional distributors and local clinics help these firms establish a foothold in a highly competitive environment. Increasing awareness of non-surgical vision correction methods, coupled with rising prevalence of myopia in North America, has further intensified competition.
Ongoing developments in lens materials and fitting technologies are set to reshape the competitive dynamics. Key companies are constantly striving to differentiate their offerings in an ever-evolving market.
Recent Industry Development
Attributes |
Details |
Forecast Period |
2024 to 2031 |
Historical Data Available for |
2019 to 2023 |
Market Analysis |
US$ Million for Value |
Key Market Segments Covered |
|
Key Companies Profiled in the Report |
|
Report Coverage |
|
Customization and Pricing |
Available upon request |
By Product Type
By Material
By Application
By End User
By Region
To know more about delivery timeline for this report Contact Sales
Yes, the market is set to reach US$ 256.2 Mn by 2031.
Overnight ortho-K lenses are estimated to witness a CAGR of 6.5% through 2031.
Its cost often ranges from US$ 1,000 to US$ 4,000 depending on the number of lenses, follow-up visits, and prescription.
Paragon Vision Sciences, Bausch + Lomb, and Euclid Systems Corporation are the key industry players.
It refers to the use of special contact lenses to temporarily reshape the cornea to enhance vision.